Image (062dc3f3 09ea 4f21 9435 025c4e9d460b 01)
Triamterene And Hydrochlorothiazide Capsule
Product Images NDC 68382-855
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 68382-855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (062dc3f3 09ea 4f21 9435 025c4e9d460b 02)
Image (062dc3f3 09ea 4f21 9435 025c4e9d460b 03)
This is a description of a drug with the National Drug Code (NDC) 68382-855-01. It comes in the form of hard gelatin capsules containing Triamterene and Hydrochlorothiazide, each at 25 mg and 5mg respectively. The drug should be stored at controlled room temperature and protected from light. It must be dispensed in a light-resistant container and kept out of reach of children. It is manufactured by Cadila Healthcare Ltd, Ahmedabad, India and distributed by Zydus Pharmaceuticals USA Inc. This drug requires a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
